Topics

Doctors not talking enough about cancer genetic testing costs

07:02 EST 7 Nov 2019 | Reuters

(Reuters Health) - About one in four U.S. oncologists rarely or never discusses the price of genomic testing with their cancer patients, even though cost is important for informed decision-making, survey results suggest.

Original Article: Doctors not talking enough about cancer genetic testing costs

NEXT ARTICLE

More From BioPortfolio on "Doctors not talking enough about cancer genetic testing costs"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...